B7-1 (CD80) as target for immunotoxin therapy for Hodgkin's disease.
Vooijs WC, Otten HG, van Vliet M, van Dijk AJ, de Weger RA, de Boer M, Bohlen H, Bolognesi A, Polito L, de Gast GC.
Vooijs WC, et al. Among authors: otten hg.
Br J Cancer. 1997;76(9):1163-9. doi: 10.1038/bjc.1997.528.
Br J Cancer. 1997.
PMID: 9365164
Free PMC article.